BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22223368)

  • 1. Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue.
    Frullanti E; Colombo F; Falvella FS; Galvan A; Noci S; De Cecco L; Incarbone M; Alloisio M; Santambrogio L; Nosotti M; Tosi D; Pastorino U; Dragani TA
    Int J Cancer; 2012 Sep; 131(5):E643-8. PubMed ID: 22223368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
    Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of differential display to identify genes for lung cancer detection in peripheral blood.
    Matsunaga H; Hangai N; Aso Y; Okano K; Kawamura M; Kobayashi K; Kambara H; Hoger JH; Mitsuhashi M
    Int J Cancer; 2002 Aug; 100(5):592-9. PubMed ID: 12124810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
    Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
    J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
    Albertus DL; Seder CW; Chen G; Wang X; Hartojo W; Lin L; Silvers A; Thomas DG; Giordano TJ; Chang AC; Orringer MB; Bigbee WL; Chinnaiyan AM; Beer DG
    J Thorac Oncol; 2008 Nov; 3(11):1236-44. PubMed ID: 18978557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.
    Manceau G; Letouzé E; Guichard C; Didelot A; Cazes A; Corté H; Fabre E; Pallier K; Imbeaud S; Le Pimpec-Barthes F; Zucman-Rossi J; Laurent-Puig P; Blons H
    Int J Cancer; 2013 May; 132(9):2217-21. PubMed ID: 23047306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma.
    Rotunno M; Hu N; Su H; Wang C; Goldstein AM; Bergen AW; Consonni D; Pesatori AC; Bertazzi PA; Wacholder S; Shih J; Caporaso NE; Taylor PR; Landi MT
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1599-608. PubMed ID: 21742797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
    Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
    Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.
    Sanmartín E; Sirera R; Usó M; Blasco A; Gallach S; Figueroa S; Martínez N; Hernando C; Honguero A; Martorell M; Guijarro R; Rosell R; Jantus-Lewintre E; Camps C
    Ann Surg Oncol; 2014 Feb; 21(2):612-20. PubMed ID: 24145997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
    Guan G; Li R; Tang W; Liu T; Su Z; Wang Y; Tan J; Jiang S; Wang K
    Tumour Biol; 2017 Mar; 39(3):1010428317691740. PubMed ID: 28347232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression in lung adenocarcinomas of smokers and nonsmokers.
    Powell CA; Spira A; Derti A; DeLisi C; Liu G; Borczuk A; Busch S; Sahasrabudhe S; Chen Y; Sugarbaker D; Bueno R; Richards WG; Brody JS
    Am J Respir Cell Mol Biol; 2003 Aug; 29(2):157-62. PubMed ID: 12600827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.
    Endoh H; Tomida S; Yatabe Y; Konishi H; Osada H; Tajima K; Kuwano H; Takahashi T; Mitsudomi T
    J Clin Oncol; 2004 Mar; 22(5):811-9. PubMed ID: 14990636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.
    Fehringer G; Liu G; Pintilie M; Sykes J; Cheng D; Liu N; Chen Z; Seymour L; Der SD; Shepherd FA; Tsao MS; Hung RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1097-104. PubMed ID: 22539604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Expression of Col11A1 Is a Marker Not only for Pancreas Carcinoma But also for Adenocarcinoma of the Papilla of Vater, Discriminating Between Carcinoma and Chronic Pancreatitis.
    Kleinert R; Prenzel K; Stoecklein N; Alakus H; Bollschweiler E; Hölscher A; Warnecke-Eberz U
    Anticancer Res; 2015 Nov; 35(11):6153-8. PubMed ID: 26504042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.